4 news items
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
BMY
18 Mar 24
and/or potential difficulties in employee retention as a result of the consummation of the transaction and (iv) completion of Bristol Myers Squibb's quarter-end
Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform
BMY
RYZB
26 Feb 24
of business partners and competitors to the consummation of the transaction and/or potential difficulties in employee retention as a result
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
BMY
RYZB
23 Feb 24
, the response of business partners and competitors to the consummation of the proposed transaction and/or potential difficulties in employee retention as a result
Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period
BMY
RYZB
12 Feb 24
of the proposed transaction and/or potential difficulties in employee retention as a result of the consummation of the proposed transaction. Forward-looking
- Prev
- 1
- Next